The method of giving the shot, like intramuscular, subcutaneous, or intravenous, affects the dose
By identifying the specific region of growth hormone responsible for lipolytic activity (amino acids 176-191) and isolating this fragment, scientists created a targeted intervention with improved safety profile, fewer contraindications, reduced side effects, and simpler monitoring requirements compared to full growth hormone
Common signs include: Fatigue and weakness Neurological changes, such as numbness or tingling in the hands and feet Megaloblastic anemia, characterized by large, abnormal red blood cells Cognitive difficulties, including memory loss and confusion Early detection and treatment of B12 deficiency can make a big difference
However, so far, no significant adverse effects have been consistently reported
Research suggests that 5-Amino-1MQ may help counteract this decline
in fact, their weight reduction was less pronounced than that of those on the lower dose